Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,878 | 162 | 131 | 507 | 1,589 |
| Receivables | 88 | 74 | 39 | 28 | 22 |
| TOTAL | $3,055 | $353 | $255 | $674 | $1,780 |
| Non-Current Assets | |||||
| PPE Net | 55 | 55 | N/A | N/A | N/A |
| Intangibles | 39 | 39 | 46 | 46 | 46 |
| TOTAL | $94 | $94 | $46 | $46 | $46 |
| Total Assets | $3,149 | $447 | $301 | $720 | $1,826 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $175 | $826 | $1,233 | $1,107 | $312 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,643 | 1,722 | N/A | N/A | N/A |
| TOTAL | $1,643 | $1,722 | $0 | $0 | $0 |
| Total Liabilities | $1,818 | $2,548 | $1,233 | $1,107 | $312 |
| Shareholders' Equity | |||||
| Common Shares | 14,993 | 10,702 | 10,520 | 9,334 | 9,005 |
| Retained earnings | -15,266 | -14,172 | -12,184 | -10,516 | -8,698 |
| Other shareholders' equity | 1,605 | 1,368 | 731 | 794 | 1,207 |
| TOTAL | $1,331 | $-2,102 | $-932 | $-388 | $1,514 |
| Total Liabilities And Equity | $3,149 | $447 | $301 | $720 | $1,826 |